Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Biotechs Develop Quicker Diagnostic For Cancer Metastases

This article was originally published in PharmAsia News

Executive Summary

Japan's Sysmex and Oncolys BioPharma say they have developed technology to use certain viruses in detecting living tumor cells as they are suspended in blood. Circulating tumor cells are blamed for cancer metastasis, but conventional diagnostics are able to detect their presence only through the proteins they secrete, and that in turns helps in identifying the size of the metastatis. Sysmex says the method it and Oncolys developed jointly allows for early detection of a possible metastasis by using a virus that replicates and emits fluorescence. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070856

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel